Matinas BioPharma Holdings, Inc. (MTNB)
0.5025
-0.05
(-8.64%)
USD |
NYAM |
Apr 07, 16:00
0.4951
-0.01
(-1.47%)
After-Hours: 20:00
Matinas BioPharma Holdings Shareholders Equity (Quarterly) : 4.83M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Savara, Inc. | 203.13M |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Imunon, Inc. | 7.062M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.208M |
| Total Liabilities (Quarterly) | 2.378M |
| Debt to Equity Ratio | 0.2803 |
| Current Ratio | 2.785 |
| Net Debt Paydown Yield | 9.15% |